Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoubao Ma

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|August 8, 2023
Application of natural killer immunotherapy in blood cancers and solid tumorsMark Sayegh, Shoubao Ma, Jianhua Yu
Cancer Treatment and Research|December 19, 2023
Recent Advances of RNA m<sup>6</sup>A Modifications in Cancer Immunoediting and ImmunotherapyShoubao Ma, Tasha Barr, Jianhua Yu
Cancer Research|August 2, 2023
Harnessing Natural Killer Cells for Lung Cancer TherapyShoubao Ma, Michael A Caligiuri, Jianhua Yu
Trends in Immunology|September 4, 2022
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapyShoubao Ma, Michael A Caligiuri, Jianhua Yu
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2025
Natural killer cell-based immunotherapy for cancerShoubao Ma, Jianhua Yu, Michael A Caligiuri
Journal of Hematology & Oncology|March 22, 2022
A four-stage model for murine natural killer cell development in vivoShoubao Ma, Michael A Caligiuri, Jianhua Yu
Chinese Medical Journal|February 7, 2024
Recent advances and remaining challenges in lung cancer therapyTasha Barr, Shoubao Ma, Zhixin Li, et al.
Cancer Research|January 6, 2026
Optimizing In Vivo CAR-T Cell Engineering for Cancer ImmunotherapyRuiheng Wang, Jianhua Yu, Michael A Caligiuri, et al.
Molecular Cancer|March 17, 2022
Targeting the RNA m<sup>6</sup>A modification for cancer immunotherapyXinxin Li, Shoubao Ma, Youcai Deng, et al.
Medscience|April 1, 2026
Emerging role of RNA modification reader YTHDF2 in hematopoiesis, immunity, and cancerXin Liu, Sai Xiao, Songqi Duan, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|August 8, 2023
Application of natural killer immunotherapy in blood cancers and solid tumorsMark Sayegh, Shoubao Ma, Jianhua Yu
Cancer Treatment and Research|December 19, 2023
Recent Advances of RNA m<sup>6</sup>A Modifications in Cancer Immunoediting and ImmunotherapyShoubao Ma, Tasha Barr, Jianhua Yu
Cancer Research|August 2, 2023
Harnessing Natural Killer Cells for Lung Cancer TherapyShoubao Ma, Michael A Caligiuri, Jianhua Yu
Trends in Immunology|September 4, 2022
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapyShoubao Ma, Michael A Caligiuri, Jianhua Yu
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2025
Natural killer cell-based immunotherapy for cancerShoubao Ma, Jianhua Yu, Michael A Caligiuri
Journal of Hematology & Oncology|March 22, 2022
A four-stage model for murine natural killer cell development in vivoShoubao Ma, Michael A Caligiuri, Jianhua Yu
Chinese Medical Journal|February 7, 2024
Recent advances and remaining challenges in lung cancer therapyTasha Barr, Shoubao Ma, Zhixin Li, et al.
Cancer Research|January 6, 2026
Optimizing In Vivo CAR-T Cell Engineering for Cancer ImmunotherapyRuiheng Wang, Jianhua Yu, Michael A Caligiuri, et al.
Molecular Cancer|March 17, 2022
Targeting the RNA m<sup>6</sup>A modification for cancer immunotherapyXinxin Li, Shoubao Ma, Youcai Deng, et al.
Medscience|April 1, 2026
Emerging role of RNA modification reader YTHDF2 in hematopoiesis, immunity, and cancerXin Liu, Sai Xiao, Songqi Duan, et al.
Pageof 5